Biotech · Public company · Florham Park, NJ, US
Celularity Inc
Ticker CELU · SEC CIK 0001752828
Track this companyFree. Adds Celularity Inc to your Dealase workspace and tells you when its record changes.
Clinical trials130 recruiting or active
Pipeline programs23From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline23
- CyclophosphamidePhase 2 · Metastatic HER2 Positive Gastroesophageal Junction CancerClinicalTrials.gov · fetched Nov 12, 2026
- CYNK-001Phase 2 · CoronavirusClinicalTrials.gov · fetched Nov 12, 2026
- CYNK-101Phase 2 · Metastatic HER2 Positive Gastroesophageal Junction CancerClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · Metastatic HER2 Positive Gastroesophageal Junction CancerClinicalTrials.gov · fetched Nov 12, 2026
- Human Placenta-Derived Cells PDA001 Intravenous InfusionPhase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PDA-002Phase 2 · Diabetic NephropathiesClinicalTrials.gov · fetched Nov 12, 2026
- PDA-002Phase 2 · Peripheral Arterial DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PDA-002Phase 2 · Diabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- PDA001Phase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Metastatic HER2 Positive Gastroesophageal Junction CancerClinicalTrials.gov · fetched Nov 12, 2026
- Recombinant Human Interleukin-2Phase 2 · Metastatic HER2 Positive Gastroesophageal Junction CancerClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabPhase 2 · Metastatic HER2 Positive Gastroesophageal Junction CancerClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle ControlPhase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- CYNK-001Phase 1 · LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CYNK-001Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- CYNK001-ITPhase 1 · Astrocytoma, Grade IVClinicalTrials.gov · fetched Nov 12, 2026
- CYNK001-IVPhase 1 · Astrocytoma, Grade IVClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- Human recombinant Interleukin-2 (rhIL-2)Phase 1 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- PNK-007Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- PNK-007Phase 1 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- rhIL-2Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) AdenocarcinomaPHASE1_PHASE2 · TERMINATED · started Apr 14, 2022ClinicalTrials.gov NCT05207722 · fetched Nov 12, 2026
- Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBMPHASE1 · TERMINATED · started Oct 1, 2020ClinicalTrials.gov NCT04489420 · fetched Nov 12, 2026
- Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19PHASE1_PHASE2 · TERMINATED · started Sep 2, 2020ClinicalTrials.gov NCT04365101 · fetched Nov 12, 2026
- Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaPHASE1 · UNKNOWN · started May 12, 2020ClinicalTrials.gov NCT04309084 · fetched Nov 12, 2026
- Natural Killer Cell (CYNK-001) Infusions in Adults with AMLPHASE1 · TERMINATED · started Mar 12, 2020ClinicalTrials.gov NCT04310592 · fetched Nov 12, 2026
- A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)PHASE1 · COMPLETED · started Jan 5, 2017ClinicalTrials.gov NCT02955550 · fetched Nov 12, 2026
- A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)PHASE1 · TERMINATED · started Jul 11, 2016ClinicalTrials.gov NCT02781467 · fetched Nov 12, 2026
- A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral NeuropathyPHASE2 · COMPLETED · started Oct 27, 2015ClinicalTrials.gov NCT02552277 · fetched Nov 12, 2026
- Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial DiseasePHASE2 · WITHDRAWN · started Jun 1, 2015ClinicalTrials.gov NCT02460081 · fetched Nov 12, 2026
- Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.PHASE2 · TERMINATED · started Oct 23, 2014ClinicalTrials.gov NCT02264288 · fetched Nov 12, 2026
- Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot UlcersPHASE1 · COMPLETED · started May 23, 2013ClinicalTrials.gov NCT01859117 · fetched Nov 12, 2026
- Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid ArthritisPHASE2 · TERMINATED · started Dec 1, 2010ClinicalTrials.gov NCT01261403 · fetched Nov 12, 2026
- PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseasePHASE2 · COMPLETED · started Aug 1, 2010ClinicalTrials.gov NCT01155362 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Oct 20, 2026 · fetched Nov 12, 2026
- 10-K/A · 10-K/ASEC EDGAR · filed Oct 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Sep 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026